Customized 3D-printed medical implants are becoming more common, and a new study has taken this technology to the next level.
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens – Biotech Investments
Biophytis / Key word(s): Miscellaneous/Miscellaneous Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens 12-Jun-2024 / 10:11 CET/CEST Biophytis